Investigation of plasma remifentanil elimination rate and improvement of safety
Not Applicable
- Conditions
- Patients who underwent sceduled operation under general anesthesia using remifentanil
- Registration Number
- JPRN-UMIN000009304
- Lead Sponsor
- Hirosaki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have severe cardiovascular disease or severe anemia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assesment of remifentanil blood concentrations at 0,1,3,5,7,10,15,20 and 30 min after termination of remifentanil infusion at 0.2 mcg/kg/min
- Secondary Outcome Measures
Name Time Method